Top Markets
#1 Official Trump Official Trump +36.70%
#2 Melania Meme Melania Meme +20.81%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +20.58%
#4 Nockchain Nockchain +20.47%
#5 EXOD EXOD +18.93%
#6 Mubarak Mubarak +17.52%
#7 MowCat MowCat +17.26%
#8 Pump.fun Pump.fun +15.83%
#9 Unit Pump Unit Pump +15.83%
#10 Wrapped POL Wrapped POL +14.46%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc.

HARP
Classement en actions #23352
Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to immunotherapy, focused on engineering a novel class of T cell activators. These therapies are designed to leverage the body's own immune system to fight cancer and other diseases in patients across the United States. The company's innovative Tri-specific T cell activating construct (TriTAC) platform forms the basis of its development pipeline. This includes HPN328, currently undergoing Phase I/II clinical trials for small cell lung cancer and tumors that express Delta-like canonical Notch ligand 3; HPN217, also in Phase I/II trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical evaluation for ovarian and pancreatic cancers, alongside other mesothelin-expressing tumors. Furthermore, Harpoon has a preclinical asset, HPN601, aimed at various solid tumor indications. The company has also established a discovery collaboration and licensing agreement with AbbVie Biotechnology Ltd. to develop and market products combining its unique TriTAC technology with soluble T cell receptors. Founded in 2015, Harpoon Therapeutics, Inc. is headquartered in South San Francisco, California.
Prix de l'action
$23.01
Dernière synchronisation: 2024-03-11
Capitalisation boursière
$74.80M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Harpoon Therapeutics, Inc. (HARP)

Catégorie

Healthcare
Le prix HARP avec la capitalisation boursière de B
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
HARP
$23.01
Capitalisation boursière de Harpoon Therapeutics, Inc.(HARP)
Capitalisation boursière: $74.80M
En August 2026, Harpoon Therapeutics, Inc. a une capitalisation boursière de $74.80M. Cela fait de Harpoon Therapeutics, Inc. la 23352nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Harpoon Therapeutics, Inc. du 2019 au 2026
HARP par rapport au top 5 des plus populaires stocks
Prix pour HARP L’actif B La capitalisation boursière de B Résultats
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
$1,603,220 $74.80M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +6,967,392.92%
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
$1,398,756 $74.80M
Apple Inc. Apple Inc.
AAPL
$4.547T +6,078,805.78%
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
$1,280,540 $74.80M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +5,565,044.67%
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
$1,105,282 $74.80M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +4,803,387.23%
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.
$859,191 $74.80M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +3,733,888.73%